See All Slides - tctmd.com

Slides

Presentation TCT 2015

TCT 73: Impact of Routine MicroNet-Covered Embolic Prevention Stent System Use on Contemporary Carotid Revascularization All-Comer PARADIGM Study

Presenter: Mark C. Bates, Mark H. Wholey, Piotr Musialek

October 13, 2015

Presentation TCT 2015

TCT 7: Trends and Outcomes of Percutaneous Coronary Intervention for Ventricular Tachycardia or Fibrillation Cardiac Arrest Analysis From Nationwide Inpatient Sample

Presenter: Eric Boersma, Richard Smalling, Nish Patel

October 13, 2015

Presentation TCT 2015

TCT 65: Two-Year Outcomes in Real-World Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent in the PROMUS Element Plus US Postapproval Study (PE-Plus PAS)

Presenter: Sigmund Silber, Philip M. Urban, David E. Kandzari

October 13, 2015

Presentation TCT 2015

TCT 57: A Cost Analysis of Bleed Complications From 2 Stroke Prevention Strategies in Nonvalvular Atrial Fibrillation: Left Atrial Appendage Closure Versus Warfarin

Presenter: Jacqueline Saw, Steven J. Yakubov, Matthew J. Price

October 13, 2015

Presentation TCT 2015

TCT 41: Invasive Assessment of Coronary Flow Reserve in Severe Aortic Stenosis With Normal Coronary Arteries

Presenter: Javier Escaned, Johan HC Reiber, Alejandro Gutierrez-Barrios

October 13, 2015

Presentation TCT 2015

Nonischemic Heart Disease, Part 2: HIV-Related CV Disease

Presenter: Hugh J. Linnehan, Mpiko Ntsekhe

October 13, 2015

Presentation TCT 2015

Presentation From France: Paravalvular Leakage During TAVI

Presenter: Alain G. Cribier, Eric Van Belle

October 13, 2015

Presentation TCT 2015

Nonischemic Heart Disease, Part 1: Rheumatic Heart Disease

Presenter: Hugh J. Linnehan, Mpiko Ntsekhe

October 13, 2015

Presentation TCT 2015

TCT 96: Self-Expanding TAVR in Patients with Failed Surgical Bioprosthesis: Results from the CoreValve US Expanded Use Study

Presenter: Jeffrey J. Popma, Mathew Williams, G. Michael Deeb

October 13, 2015

Presentation TCT 2015

TCT 88: Transcatheter Perivascular Chemical Neurolysis to Produce Renal Denervation Targeted, Local Delivery of Alcohol as a Viable Alternative to Radiofrequency Approaches

Presenter: Michael A. Weber, Stephen G. Worthley, Tim A. Fischell

October 13, 2015

Advertisement

Slides

TCT 73: Impact of Routine MicroNet-Covered Embolic Prevention Stent System Use on Contemporary Carotid Revascularization All-Comer PARADIGM Study

TCT 7: Trends and Outcomes of Percutaneous Coronary Intervention for Ventricular Tachycardia or Fibrillation Cardiac Arrest Analysis From Nationwide Inpatient Sample

TCT 65: Two-Year Outcomes in Real-World Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent in the PROMUS Element Plus US Postapproval Study (PE-Plus PAS)

TCT 57: A Cost Analysis of Bleed Complications From 2 Stroke Prevention Strategies in Nonvalvular Atrial Fibrillation: Left Atrial Appendage Closure Versus Warfarin

TCT 41: Invasive Assessment of Coronary Flow Reserve in Severe Aortic Stenosis With Normal Coronary Arteries

Nonischemic Heart Disease, Part 2: HIV-Related CV Disease

Presentation From France: Paravalvular Leakage During TAVI

Nonischemic Heart Disease, Part 1: Rheumatic Heart Disease

TCT 96: Self-Expanding TAVR in Patients with Failed Surgical Bioprosthesis: Results from the CoreValve US Expanded Use Study

TCT 88: Transcatheter Perivascular Chemical Neurolysis to Produce Renal Denervation Targeted, Local Delivery of Alcohol as a Viable Alternative to Radiofrequency Approaches

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content